Re-irradiation plus pembrolizumab: Phase II study for recurrent glioblastoma patients.
Iwamoto FM, Tanguturi SK, Nayak L, Wang TJ, Desai A, Lustig RA, Bagley S, Wong ET, Hertan LM, McCluskey C, Hayden J, Muzikansky A, Nakhawa S, Japo J, Bossi CC, Meylan M, Tian Y, Barlow GL, Speliakos P, Ayoub G, Meredith DM, Ligon KL, Haas-Kogan D, Huang K, Wucherpfennig KW, Wen PY, Reardon DA.
Iwamoto FM, et al. Among authors: lustig ra.
Clin Cancer Res. 2024 Nov 8. doi: 10.1158/1078-0432.CCR-24-1629. Online ahead of print.
Clin Cancer Res. 2024.
PMID: 39513953